Our Science
-
Therapeutic Focus
Our therapeutic focus is Parkinson’s Disease
-
Therapeutic Target
We are targeting TLR2 and Alpha-synuclein
-
Strategic Approach
Our disease modifying approach prevents alpha-synuclein propagation and neuroinflammation
-
Open Innovation
We work together with industry and academia to find cure for patients